Lin Gui Selected Research

N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamide

10/2021

Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Gui Research Topics

Disease

36	Neoplasms (Cancer) 12/2023 - 01/2005
15	Lymphoma (Lymphomas) 01/2023 - 06/2012
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2023 - 02/2015
8	Thrombosis (Thrombus) 01/2019 - 07/2010
7	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2015
5	Disease Progression 12/2023 - 01/2020
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022 - 10/2009
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2021 - 03/2013
5	Neutropenia 01/2018 - 10/2009
5	Thrombocytopenia (Thrombopenia) 01/2018 - 10/2009
4	Inflammation (Inflammations) 01/2018 - 01/2017
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 05/2013
3	Anaplastic Thyroid Carcinoma 12/2023 - 01/2021
3	T-Cell Lymphoma (Lymphoma, T Cell) 10/2023 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2020 - 04/2010
3	Nasopharyngeal Carcinoma 01/2020 - 08/2015
3	Anemia 01/2018 - 02/2016
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2023 - 02/2015
2	Extranodal NK-T-Cell Lymphoma 09/2022 - 11/2019
2	Wounds and Injuries (Trauma) 05/2022 - 07/2013
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2021 - 01/2021
2	Lymphatic Metastasis 01/2020 - 04/2018
2	Carcinogenesis 04/2018 - 09/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015 - 02/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2013 - 03/2013
1	Hypoxia (Hypoxemia) 05/2024
1	Leukopenia 12/2023
1	Hypertriglyceridemia 12/2023
1	COVID-19 01/2023
1	Ischemic Stroke 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 09/2023 - 09/2015
8	Gemcitabine FDA Link 11/2019 - 03/2013
7	Guanosine Diphosphate (GDP)IBA 11/2019 - 03/2013
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019 - 07/2015
6	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 09/2015
5	Peptides (Polypeptides)IBA 03/2023 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2009
5	P-SelectinIBA 01/2018 - 01/2017
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 09/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2014
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 08/2014
4	B-Cell Activating FactorIBA 01/2016 - 05/2013
3	Monoclonal AntibodiesIBA 09/2023 - 04/2016
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 09/2015
3	AnthracyclinesIBA 09/2022 - 11/2019
3	PlatinumIBA 01/2020 - 08/2015
3	Interleukin-8 (Interleukin 8)IBA 01/2018 - 01/2017
3	Ifosfamide FDA LinkGeneric 09/2015 - 07/2015
2	TOR Serine-Threonine KinasesIBA 12/2023 - 12/2019
2	Anaplastic Lymphoma KinaseIBA 10/2023 - 02/2015
2	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2021
2	anlotinibIBA 01/2023 - 01/2021
2	sintilimabIBA 01/2023 - 01/2021
2	RutheniumIBA 08/2021 - 04/2021
2	GoldIBA 08/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2019
2	AcidsIBA 01/2019 - 02/2017
2	ParaffinIBA 01/2019 - 08/2012
2	Formaldehyde (Formol)FDA Link 01/2019 - 08/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2017
2	imidazo(1,2-a)quinoxaline-2-carboxylic acidIBA 01/2018 - 02/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2017
2	Etoposide (VP 16)FDA LinkGeneric 10/2017 - 09/2015
2	PyransIBA 09/2017 - 01/2017
2	Carboxylic AcidsIBA 09/2017 - 01/2017
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2014 - 07/2009
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2014 - 05/2013
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2013 - 03/2013
1	Glutathione (Reduced Glutathione)IBA 05/2024
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 12/2023
1	phytochlorinIBA 12/2023
1	Alanine Transaminase (SGPT)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023
1	Protons (Proton)IBA 03/2023
1	Drug CarriersIBA 03/2023
1	pembrolizumabIBA 01/2023
1	dabrafenibIBA 01/2023
1	trametinibIBA 01/2023
1	azvudineIBA 01/2023
1	EdaravoneIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 01/2023 - 10/2009
13	Therapeutics 12/2023 - 01/2005
4	Radiotherapy 11/2019 - 09/2015
3	Immunotherapy 12/2023 - 01/2021
3	Stem Cell Transplantation 04/2022 - 01/2014
2	VAP-cyclo protocol 01/2023 - 10/2015
2	Neoadjuvant Therapy 01/2023 - 01/2020
2	Chemoradiotherapy 06/2022 - 01/2021
2	Photothermal Therapy 05/2022 - 03/2022
2	Hematopoietic Stem Cell Transplantation 10/2017 - 06/2012
1	Photochemotherapy (Photodynamic Therapy) 12/2023
1	Length of Stay 01/2023